2008 & 2009 GRAND awards

 

2009 GRAND AWARDS
 
The Global Research Awards for Nicotine Dependence (GRAND) for 2009 have been awarded to the following projects, which are listed in alphabetical order by applicant surname. Please click on the proposal title for a brief description of each project.
 
  
Name Affiliation Proposal Title
Bolliger, PhD, MD Faculty of Health Sciences Respiratory Research Unit, Quit Support, South Africa Varenicline in combination with nicotine replacement therapy for smoking cessation
DiFranza, MD University of Massachusetts Medical School, Massachusetts, USA BDNF – A potential biomarker of nicotine withdrawal
Graham, PhD, MS, FNP The Ohio State University College of Nursing, Columbus, USA Web-based smoking cessation for women: A pilot study
Jackson, PhD University of Brighton, Brighton, UK Effect of varenicline on inhibitory control in smokers
Le Foll, MD, PhD, CCFP University of Toronto, Ontario, Canada A C11 PHNO PET study in smokers to measure the dopamine-releasing effects of presentation of tobacco-associated stimuli
Polosa, MD, PhD University of Catania, Catania, Italy Efficacy of smoking cessation with varenicline in diabetic smokers: A randomized controlled trial
Wadland, MD, MS Michigan State University, East Lansing, USA Preventing relapse to smoking in post partum women

 

2008 GRAND AWARDS

The Global Research Awards for Nicotine Dependence (GRAND) for 2008 have been awarded to the following projects, which are listed in alphabetical order by applicant surname. Please click on the proposal title for a brief description of each project.

$US50,000 (Junior Researcher) Awards

Name Affiliation Proposal Title
Li-Shiun Chen, MD Washington University, St Louis, USA Nicotine dependence: synthesizing genetic and environmental risks
Karen Hartwell, MD Medical University of South Carolina, USA The impact of varenicline on BOLD fMRI activation during smoking cue-induced craving in nicotine-dependent individuals
Jean-Charles Hoda, PhD University of Geneva, Switzerland Functional properties of a genetic risk variant in the α5 subunit of nicotinic acetylcholine receptors associated with nicotine dependence and lung cancer
Amy Lazev, PhD Fox Chase Cancer Center, Philadelphia, USA A new treatment for smokers with high negative affect
Bernard Le Foll, MD, PhD Centre for Addiction and Mental Health, Toronto, Canada Role of insula in nicotine-seeking behavior in rats
James MacKillop, PhD Brown University, USA Understanding craving for cigarettes via behavioral economics

 $US150,000 Awards

Name   Affiliation Proposal Title
Eric Donny, PhD University of Pittsburgh, USA Neurobiological correlates of reward dysfunction in daily smokers varying in nicotine dependence
Jaakko Kaprio, MD, PhD University of Helsinki, Finland Finnish genetic epidemiologic study on nicotine dependence and smoking cessation
Milan Khara, MBChB University of British Columbia, Canada An examination of the efficacy, safety, and sex and gender differences in using varenicline as an aid to smoking cessation in a population of methadone maintained opioid dependent patients: a pilot trial
Martin Mahoney, MD, PhD Rosswell Park Cancer Institute, New York, USA Extended pre-cessation varenicline for smoking cessation: a pilot study
Marc Mooney, PhD University of Minnesota, USA Human laboratory evaluation of combination pharmacotherapy for nicotine dependence: varenicline and bupropion
Andrew Strasser, PhD University of Pennsylvania, USA Extinction of smoking topography and behaviors during response to varenicline